115 related articles for article (PubMed ID: 35617990)
1. COVID-19 vaccine effectiveness in patients with cancer: remaining vulnerabilities and uncertainties.
Kuderer NM; Lyman GH
Lancet Oncol; 2022 Jun; 23(6):693-695. PubMed ID: 35617990
[No Abstract] [Full Text] [Related]
2. COVID-19 Vaccine Effectiveness in Youth Varies by Age, Variant.
Kuehn BM
JAMA; 2022 Apr; 327(16):1540. PubMed ID: 35471503
[No Abstract] [Full Text] [Related]
3. mRNA Booster Improves a COVID-19 Vaccine's Effectiveness.
Kuehn BM
JAMA; 2022 May; 327(18):1749. PubMed ID: 35536258
[No Abstract] [Full Text] [Related]
4. Covid-19: Vaccine effectiveness wanes more rapidly for cancer patients, study finds.
Wise J
BMJ; 2022 May; 377():o1305. PubMed ID: 35609918
[No Abstract] [Full Text] [Related]
5. Correspondence on 'COVID-19 vaccine efficacy in a rapidly changing landscape'.
Mungmunpuntipantip R; Wiwanitkit V
J Investig Med; 2022 Aug; 70(6):1442. PubMed ID: 35970541
[No Abstract] [Full Text] [Related]
6. COVID-19 vaccines: effectiveness and number needed to treat.
Correia LCL; Matias D
Lancet Microbe; 2021 Jul; 2(7):e281. PubMed ID: 34027506
[No Abstract] [Full Text] [Related]
7. COVID-19 Vaccine Efficacy in Liver Transplant Recipients: A Rising Concern.
Zahid M; Irshad N; Azhar N; Ahmed J
Balkan Med J; 2022 Jan; 39(1):78-79. PubMed ID: 35330549
[No Abstract] [Full Text] [Related]
8. COVID-19 Vaccine Effectiveness in a Diverse Urban Health Care Worker Population.
Iliaki E; Lan FY; Christophi CA; Guidotti G; Jobrack AD; Buley J; Osgood R; Bruno-Murtha LA; Kales SN
Mayo Clin Proc; 2021 Dec; 96(12):3180-3182. PubMed ID: 34863402
[No Abstract] [Full Text] [Related]
9. Host factors and vaccine efficacy: Implications for COVID-19 vaccines.
Falahi S; Kenarkoohi A
J Med Virol; 2022 Apr; 94(4):1330-1335. PubMed ID: 34845730
[TBL] [Abstract][Full Text] [Related]
10. Understanding Covid Vaccine Efficacy over Time - Bridging a Gap Between Public Health and Health Care.
Kohane I; Omenn GS
N Engl J Med; 2022 Aug; 387(6):483-485. PubMed ID: 35929811
[No Abstract] [Full Text] [Related]
11. Reply to Fung et al. on COVID-19 vaccine case-counting window biases overstating vaccine effectiveness.
Lataster R
J Eval Clin Pract; 2024 Feb; 30(1):82-85. PubMed ID: 37403424
[No Abstract] [Full Text] [Related]
12. Translating inspiration from COVID-19 vaccine trials to innovations in clinical cancer research.
Choudhury NJ; Riely GJ; Sabbatini PJ; Hellmann MD
Cancer Cell; 2021 Jul; 39(7):897-899. PubMed ID: 34004186
[No Abstract] [Full Text] [Related]
13. Evaluating real-world COVID-19 vaccine effectiveness using a test-negative case-control design.
Reynolds MW; Secora A; Joules A; Albert L; Brinkley E; Kwon T; Mack C; Toovey S; Dreyer NA
J Comp Eff Res; 2022 Nov; 11(16):1161-1172. PubMed ID: 36148919
[No Abstract] [Full Text] [Related]
14. Analysis of Vaccine Effectiveness Against COVID-19 and the Emergence of Delta and Other Variants of Concern in Utah.
Keegan LT; Truelove S; Lessler J
JAMA Netw Open; 2021 Dec; 4(12):e2140906. PubMed ID: 34940869
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of COVID-19 vaccine response in patients with cancer: An interim analysis.
Tran S; Truong TH; Narendran A
Eur J Cancer; 2021 Dec; 159():259-274. PubMed ID: 34798454
[TBL] [Abstract][Full Text] [Related]
16. Comparative vaccine effectiveness against severe COVID-19 over time in US hospital administrative data: a case-control study.
Wright BJ; Tideman S; Diaz GA; French T; Parsons GT; Robicsek A
Lancet Respir Med; 2022 Jun; 10(6):557-565. PubMed ID: 35227415
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of Ad26.COV2.S Vaccine vs BNT162b2 Vaccine for COVID-19 Hospitalizations.
Botton J; Semenzato L; Jabagi MJ; Baricault B; Weill A; Dray-Spira R; Zureik M
JAMA Netw Open; 2022 Mar; 5(3):e220868. PubMed ID: 35234883
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of mRNA-1273 and BNT162b2 Vaccines in Qatar.
Abu-Raddad LJ; Chemaitelly H; Bertollini R;
N Engl J Med; 2022 Feb; 386(8):799-800. PubMed ID: 35045222
[No Abstract] [Full Text] [Related]
19. Durability of Booster mRNA Vaccine against SARS-CoV-2 BA.2.12.1, BA.4, and BA.5 Subvariants.
Qu P; Faraone JN; Evans JP; Zheng YM; Yu L; Ma Q; Carlin C; Lozanski G; Saif LJ; Oltz EM; Gumina RJ; Liu SL
N Engl J Med; 2022 Oct; 387(14):1329-1331. PubMed ID: 36069925
[No Abstract] [Full Text] [Related]
20. Studies Suggest COVID-19 Vaccine Boosters Save Lives.
Abbasi J
JAMA; 2022 Jan; 327(2):115. PubMed ID: 35015054
[No Abstract] [Full Text] [Related]
[Next] [New Search]
